Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2021 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

• Verrica Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -9.7 M, a 0.62% decrease year-over-year.
• Verrica Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -19.5 M, a 77.11% decrease year-over-year.
• Verrica Pharmaceuticals Inc. annual net income for 2025 was -17.9 M, a 76.64% decrease from 2024.
• Verrica Pharmaceuticals Inc. annual net income for 2024 was -76.6 M, a 14.31% increase from 2023.
• Verrica Pharmaceuticals Inc. annual net income for 2023 was -67.0 M, a 173.59% increase from 2022.
• Verrica Pharmaceuticals Inc. annual net income for 2022 was -24.5 M.